Revance Therapeutics, Stock Forecast - Price Action Indicator
| RVNCDelisted Stock | USD 3.65 0.00 0.00% |
Revance Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Revance Therapeutics, stock prices and determine the direction of Revance Therapeutics,'s future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Revance Therapeutics,'s historical fundamentals, such as revenue growth or operating cash flow patterns.
Revance |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.34) | (0.15) |
| Check Revance Therapeutics, Volatility | Backtest Revance Therapeutics, | Trend Details |
Revance Therapeutics, Trading Date Momentum
| On December 02 2024 Revance Therapeutics, was traded for 3.73 at the closing time. The top price for the day was 3.76 and the lowest listed price was 3.55 . The trading volume for the day was 1.3 M. The trading history from December 2, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 3.32% . The trading delta at closing time against the current closing price is 6.93% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Revance Therapeutics, to competition
View Revance Therapeutics, Related Equities
| Risk & Return | Correlation |
Revance Therapeutics, Market Strength Events
Market strength indicators help investors to evaluate how Revance Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Revance Therapeutics, shares will generate the highest return on investment. By undertsting and applying Revance Therapeutics, stock market strength indicators, traders can identify Revance Therapeutics, entry and exit signals to maximize returns.
Revance Therapeutics, Risk Indicators
The analysis of Revance Therapeutics,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Revance Therapeutics,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting revance stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.04 | |||
| Standard Deviation | 6.54 | |||
| Variance | 42.72 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Revance Stock
If you are still planning to invest in Revance Therapeutics, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Revance Therapeutics,'s history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |